רווח למניה בשנים עשר החודשים האחרונים: MangoRx (MGRX)

The TTM net income per share reflects the profitability dynamics of Mangoceuticals, Inc. (MGRX), where -1.16 characterizes this valuation parameter. The financial result is based on user acquisition costs and compliance with online pharmacy regulations. The scaling of MangoRx and the development of the subscription service are driving growth. Ambitious management is ensuring a rapid surge in revenue, although the market is awaiting the optimization of current expenses.

Mangoceuticals, Inc. (MGRX) revenues depend directly on customer acquisition costs within the men's telemedicine segment and regulatory standards. This indicator measures the actual annual earnings per share, excluding management's accounting manipulations. Rising values signal marketing efficiency and business scaling. Analyzing the fundamental net income per share TTM allows for timely portfolio rebalancing. The trend in fundamental net income per share TTM reflects the market consensus on the cost of capital.